Cited 0 times in
Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박지혜 | - |
dc.contributor.author | 천재희 | - |
dc.date.accessioned | 2021-09-29T05:33:09Z | - |
dc.date.available | 2021-09-29T05:33:09Z | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 1976-2283 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/185094 | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Editorial Office of Gut and Liver | - |
dc.relation.isPartOf | GUT AND LIVER | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease? | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jihye Park | - |
dc.contributor.googleauthor | Jae Hee Cheon | - |
dc.identifier.doi | 10.5009/gnl210345 | - |
dc.contributor.localId | A04575 | - |
dc.contributor.localId | A04030 | - |
dc.relation.journalcode | J00954 | - |
dc.identifier.eissn | 2005-1212 | - |
dc.identifier.pmid | 34521776 | - |
dc.contributor.alternativeName | Park, Ji Hye | - |
dc.contributor.affiliatedAuthor | 박지혜 | - |
dc.contributor.affiliatedAuthor | 천재희 | - |
dc.citation.volume | 15 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 641 | - |
dc.citation.endPage | 642 | - |
dc.identifier.bibliographicCitation | GUT AND LIVER, Vol.15(5) : 641-642, 2021-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.